Sakamoto A - Search Results

1

Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.

Kawaguchi K, Oda Y, Sakamoto A, Saito T, Tamiya S, Iwamoto Y, Tsuneyoshi M. Kawaguchi K, et al. Among authors: sakamoto a. Mod Pathol. 2002 Aug;15(8):878-88. doi: 10.1097/01.MP.0000024264.48690.EA. Mod Pathol. 2002. PMID: 12181274

2

N-ras mutation of thyroid tumor with special reference to the follicular type.

Oyama T, Suzuki T, Hara F, Iino Y, Ishida T, Sakamoto A, Nakajima T. Oyama T, et al. Among authors: sakamoto a. Pathol Int. 1995 Jan;45(1):45-50. doi: 10.1111/j.1440-1827.1995.tb03378.x. Pathol Int. 1995. PMID: 7704243

3

Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas.

Dobashi Y, Sugimura H, Sakamoto A, Mernyei M, Mori M, Oyama T, Machinami R. Dobashi Y, et al. Among authors: sakamoto a. Diagn Mol Pathol. 1994 Mar;3(1):9-14. doi: 10.1097/00019606-199403010-00003. Diagn Mol Pathol. 1994. PMID: 8162258

4

Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity.

Yamauchi N, Sakamoto A, Uozaki H, Iihara K, Machinami R. Yamauchi N, et al. Among authors: sakamoto a. Int J Gynecol Pathol. 1996 Jul;15(3):202-8. doi: 10.1097/00004347-199607000-00003. Int J Gynecol Pathol. 1996. PMID: 8811380

5

Immunohistochemical study of p21WAF1 and p53 proteins in prostatic cancer and their prognostic significance.

Matsushima H, Sasaki T, Goto T, Hosaka Y, Homma Y, Kitamura T, Kawabe K, Sakamoto A, Murakami T, Machinami R. Matsushima H, et al. Among authors: sakamoto a. Hum Pathol. 1998 Aug;29(8):778-83. doi: 10.1016/s0046-8177(98)90445-2. Hum Pathol. 1998. PMID: 9712417

6

Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.

Oda Y, Sakamoto A, Shinohara N, Ohga T, Uchiumi T, Kohno K, Tsuneyoshi M, Kuwano M, Iwamoto Y. Oda Y, et al. Among authors: sakamoto a. Clin Cancer Res. 1998 Sep;4(9):2273-7. Clin Cancer Res. 1998. PMID: 9748149

7

Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.

Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M. Sakamoto A, et al. J Cancer Res Clin Oncol. 1999 Oct;125(10):541-8. doi: 10.1007/s004320050314. J Cancer Res Clin Oncol. 1999. PMID: 10473866

8

A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to expressions of c-fos and c-jun products and bone matrix proteins: a clinicopathologic review and immunohistochemical study of c-fos, c-jun, type I collagen, osteonectin, osteopontin, and osteocalcin.

Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M. Sakamoto A, et al. Hum Pathol. 1999 Dec;30(12):1418-26. doi: 10.1016/s0046-8177(99)90162-4. Hum Pathol. 1999. PMID: 10667418

9

Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.

Motoi N, Sakamoto A, Yamochi T, Horiuchi H, Motoi T, Machinami R. Motoi N, et al. Among authors: sakamoto a. Pathol Res Pract. 2000;196(1):1-7. doi: 10.1016/S0344-0338(00)80015-1. Pathol Res Pract. 2000. PMID: 10674266

10

Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma.

Oda Y, Sakamoto A, Saito T, Kinukawa N, Iwamoto Y, Tsuneyoshi M. Oda Y, et al. Among authors: sakamoto a. Hum Pathol. 2000 Feb;31(2):185-92. doi: 10.1016/s0046-8177(00)80218-x. Hum Pathol. 2000. PMID: 10685632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,901 results

Search Page

Filters